Medical and health innovation is at the time, how can capital help its development?

In recent years, with the development of the socio-economic level and the increase in health needs, innovation in China's medical and health industry has become a boom.

So in the field of medical and health innovation, how does capital choose the direction? What suggestions have you put forward for the innovation and development of the enterprise? On April 22, at the 2021 Taihu Bay Life and Health Future Conference, He Weiwu, founder of ETP Zhihe Kangdao Investment (host of the roundtable dialogue), Hillhouse Co-Chief Investment Officer and partner Yi Nuoqing, founder of Honghui Capital , CEO Wang Hui, Executive Director Huang Xiao of Yunfeng Fund and Ye Xiaoping, Chairman of Tigermed, conducted a roundtable dialogue with the theme of "Capital assists medical and health innovation" around the above issues, and proposed how capital can promote the development of medical and health innovation.

Capital assistance (round table).

Round table dialogue scene (source: the same freehand brushwork)

What are investors looking at?

What are the factors that determine capital investment? Tuyere, track, or innovative technology? In fact, every investor has his own opinion on this issue.

"Our feeling is to invest in innovation.

Hillhouse Yi Nuoqing.

Huang Xiao also agrees with the view of investment innovation.

As the initiator of Alibaba Health, Yunfeng Fund participated in the strategic financing of Alibaba Health in 2014.

For Wang Hui, who is both an entrepreneur and an investor, Honghui talks about "two respects", namely, respect for growth and respect for young people, when setting up the medical and health track.

Respecting young people, listening to them, and serving them is the consistent follow of Honghui Capital.

Viewing Enterprise Development from the Perspective of Capital

Under the wave of medical and health innovation, more and more entrepreneurs are entering the medical and health field, various policies are constantly being introduced, and the market is also in a state of constant change.

Yi Nuoqing believes that companies need to focus more resources and attention on more cutting-edge innovations, not to do too much repetitive construction, but to rely on the best talents to engage in internationalization earlier.

Secondly, Hillhouse also has its own views on the two major events of centralized procurement and medical insurance negotiations that many companies in the industry are concerned about.

Ye Xiaoping said that looking at the development of an enterprise from an investment perspective, the choice of track direction is basically the same, and the team's strength is still the main factor in the development.

Huang Xiao said that the values ​​of talents and organizational vision are particularly important.
The later the enterprise develops, the more it needs to rely on the strength of people, the strength of the team, and the strength of execution.

"Taking Wuxi's future development as an example, there are two things to pay attention to.
The first is the differentiated development in direction, finding opportunities for overtaking in corners in terms of new antibodies, and the second is seeking changes in payment innovation.
The annual public financial budget of approximately 170 billion will use several billion to support the payment of innovative drugs.
This will not only become an innovative project, but also become popular, and the burden on the government will not be too heavy, so it is also worth considering Direction of development.
"

Wang Hui finally added that an optimistic attitude is also an indispensable and important quality for enterprises.
For entrepreneurs, starting a business is a life-or-death journey.
The road is full of thorns, and it is only by maintaining an optimistic and happy attitude.